Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – Here’s Why

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 79,870 shares traded hands during trading, an increase of 107% from the previous session’s volume of 38,560 shares.The stock last traded at $61.89 and had previously closed at $61.73.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 25th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Novozymes A/S currently has an average rating of “Hold”.

Check Out Our Latest Research Report on NVZMY

Novozymes A/S Price Performance

The stock has a market cap of $29.07 billion, a PE ratio of 36.73, a P/E/G ratio of 1.15 and a beta of 0.96. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.07 and a current ratio of 1.75. The business has a 50 day moving average price of $62.03 and a two-hundred day moving average price of $66.15.

Novozymes A/S Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, September 11th. Shareholders of record on Wednesday, September 3rd were paid a $0.1856 dividend. This represents a yield of 88.0%. The ex-dividend date was Tuesday, September 2nd. Novozymes A/S’s dividend payout ratio is 21.89%.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Recommended Stories

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.